{"id":755723,"date":"2025-08-07T14:18:02","date_gmt":"2025-08-07T14:18:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=755723"},"modified":"2025-08-07T14:18:02","modified_gmt":"2025-08-07T14:18:02","slug":"vascular-access-device-market-to-reach-905-billion-by-2030-strategic-opportunities","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/vascular-access-device-market-to-reach-905-billion-by-2030-strategic-opportunities_755723.html","title":{"rendered":"Vascular Access Device Market to Reach $9.05 Billion by 2030: Strategic Opportunities"},"content":{"rendered":"
\n
\"Vascular<\/a><\/div>\n
\n
Prominent players in the Vascular access device market include, Becton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Medtronic (Ireland)<\/div>\n<\/div>\n<\/div>\n
Browse 664 market data Tables and 64 Figures spread through 460 Pages and in-depth TOC on “Vascular Access Devices Market by Type (Central (PICC, Tunneled, Non-Tunnled, Port (Conventional, Power)), Peripheral (Venous (PIVC, Midline), Arterial) Intraosseous Device), Route of Insertion (IV, SC, IO), Application, End User – Global Forecast to 2030<\/div>\n

The vascular access device (VAD) market<\/a><\/strong> is undergoing a transformative shift, projected to grow from USD 5.99 billion in 2024 to USD 9.05 billion by 2030<\/strong>, at a CAGR of 7.1%<\/strong>. This growth is not just about numbers—it represents a significant strategic opportunity<\/strong> for healthcare providers, medical device manufacturers, and investors looking to capitalize on a market critical to modern patient care.<\/p>\n

As the demand for long-term intravenous therapies, oncology treatments, and chronic disease management<\/strong> increases globally, vascular access devices have become indispensable. These devices—including central venous catheters, peripherally inserted central catheters (PICCs), implantable ports, and peripheral IV catheters<\/strong>—enable efficient delivery of medications, nutrients, and diagnostic agents.<\/p>\n

Download PDF Brochure:<\/a> <\/strong><\/p>\n

What’s Driving Market Growth?<\/strong><\/p>\n

    \n
  1. Rising Chronic Illnesses and Hospital Admissions<\/strong> Aging populations and increasing chronic disease incidence (e.g., cancer, kidney failure) have amplified the need for long-term IV access solutions.<\/li>\n
  2. Healthcare Infrastructure Modernization in Emerging Markets<\/strong> Expanding hospital networks and public-private partnerships in regions like Asia-Pacific, Latin America, and the Middle East are driving product adoption and expanding vendor opportunities.<\/li>\n
  3. Technological Innovations and R&D Investments<\/strong> Companies are actively investing in next-generation vascular devices<\/strong> with anti-infective coatings, pressure injectability, and smart integration capabilities.<\/li>\n<\/ol>\n

    Key Market Leaders and Their Strategic Moves<\/strong><\/p>\n

    Becton, Dickinson and Company (BD) – Dominance Through Scale and Innovation<\/strong><\/p>\n

    BD has cemented its position as a global leader by leveraging its broad product portfolio and global reach across 61 countries<\/strong>. Through its BD Medical and BD Interventional units, the company provides PICCs, CVCs, dialysis catheters, and implantable ports<\/strong>—addressing both acute and chronic care needs.<\/p>\n

    Teleflex Incorporated – R&D-Fueled Global Expansion<\/strong><\/p>\n

    Teleflex’s ARROW-branded vascular access devices<\/strong> are recognized for innovation. The company invested USD 154.4 million in R&D in FY 2023<\/strong> and has made strategic product launches—such as the Arrowg+ard Blue Plus Catheter<\/strong>—tailored to EMEA markets.<\/p>\n

    ICU Medical – Portfolio Diversification and Strategic Acquisitions<\/strong><\/p>\n

    With a comprehensive offering that includes CVCs, IV catheters, intraosseous needles, and needle-free connectors<\/strong>, ICU Medical has built a reputation for regulatory compliance and quality. Its 2022 acquisition of Smiths Medical<\/strong> expanded its vascular access portfolio and market reach.<\/p>\n

    Request Sample Pages : <\/a><\/strong><\/p>\n

    Market Outlook: Where the Opportunities Lie<\/strong><\/p>\n

    For decision-makers in the medical device<\/strong>, hospital procurement<\/strong>, and investment<\/strong> sectors, this market represents a high-yield, low-volatility growth segment.<\/p>\n